64
Views
16
CrossRef citations to date
0
Altmetric
Review

Fixed-dose combinations at the front line of multimodal pain management: perspective of the nurse-prescriber

, , , , , , & show all
Pages 9-22 | Published online: 04 Feb 2013

References

  • Langley [webpage on the Internet]. The prevalence, correlates and treatment of pain in the European Union. Curr Med Res Opin. 2011;27:463–480.
  • American Academy of Pain Medicine. AAPM Facts and Figures on Pain. 2011. Available from: http://www.painmed.org/patient/facts.html. Accessed July 5, 2011.
  • Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287–333.
  • Brown S, Kirkpatrick M, Swansson M, McKenzie I. Pain experience in the elderly. Pain Manage Nurs. 2011;12:190–196.
  • Pergolizzi J, Ahlbeck K, Aldington D, et al. The chronic pain conundrum: should we CHANGE from relying on past history to assessing prognostic factors? Curr Med Res Opin. 2012;28: 249–256.
  • Treede RD, Jensen T, Campbell J, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–1635.
  • Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 2009;13:185–190.
  • Friessem C, Willweber-Strumpf A, Zenz M. Chronic pain in primary care. German figures from 1991 and 2006. BMC Public Health. 2009 9:299.
  • Raffa R. Pharmacology of oral combination analgesics: rational therapy for pain. J Clin Pharm Ther. 2001;26:257–264.
  • Elliott T, Renier C, Palcher J. Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med. 2003; 4:331–339.
  • Becker N, Thomsen A, Olsen A, Sjogren P, Bech P, Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain. 1997;73:393–400.
  • Hunfeld J, Perquin C, Duivenvoorden H, et al. Chronic pain and its impact on quality of life in adolescents and their families. J Pediatr Psychol. 2001;26:145–153.
  • Lamé I, Peters M, Vlaeyen J, Kleef M, Patijn J. Quality of life in chronic pain is more associated with beliefs about pain, than with pain intensity. Eur J Pain. 2005;9:15–24.
  • Terwindt G, Ferrari M, Tijhuis M, Groenen A, Picavet J, Launer L. The impact of migraine on quality of life in the general population: the GEM study. Neurology. 2000;55:624–629.
  • Jensen M, Chodroff M, Dworkin R. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007;68:1178–1182.
  • Skevington SM, Carse MS, Williams AC. Validation of the WHOQOL-100: pain management improves quality of life for chronic pain patients. Clin J Pain. 2001;17:264–275.
  • Überall M, Müller-Schwefe G. Patient perceptions associated with the 5% lidocaine medicate plaster in daily practice. Curr Med Res Opin. 2012;28:901–909.
  • Überall M, Müller-Schwefe G. Low-dose 7-day transdermal buprenorphine in daily clinical practice – perceptions of patients with moderate nonmalignant chronic pain. Curr Med Res Opin. 2012;28: 1585–1595.
  • Varrassi G, Müller-Schwefe G, Pergolizzi J, et al. Pharmacological treatment of chronic pain – the need for CHANGE. Curr Med Res Opin. 2010;26:1231–1245.
  • Ott B. Progress in ethical decision making in the care of the dying. Dimens Crit Care Nurs. 2010;29:73–80.
  • World Health Organization. Achieving Balance in National Opioids Control Policy – Guidelines for Assessment. Geneva, Switzerland: World Health Organization; 2000.
  • World Health Organization. Cancer pain relief with a guide to opioid availability. 1996. Available from: http://www.painpolicy.wisc.edu/publicat/11WHOGLs/WHOGLs.pdf. Accessed May 12, 2011.
  • World Health Organization. National Cancer Control Programmes: Policies and Management Guidelines. Geneva, Switzerland: World Health Organization; 2002.
  • Langley P, Müller-Schwefe G, Nicolaou A, Liedgens H, Pergolizzi J, Varrassi G. The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilization. J Med Econ. 2010;13:571–581.
  • Robbins L. Refractory chronic migraine: long-term follow-up using a refractory rating scale. J Headache Pain. 2012;13:225–229.
  • Kreitler S, Niv D. Cognitive impairment in chronic pain. Pain Clin Updates. 2007;15:1–4.
  • Lee DM, Pendleton N, Tajar A, et al. Chronic widespread pain is associated with slower cognitive processing speed in middle-aged and older European men. Pain. 2010;151:30–36.
  • Langley P, Müller-Schwefe G, Nicolaou A, Liedgens H, Pergolizzi J, Varrassi G. The impact of pain on labor force participation, absenteeism and presenteeism in the European Union. J Med Econ. 2010;13: 662–672.
  • Gore M, Sadosky A, Stacey BR, Tai KS, Leslie D. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and healthcare costs in usual care settings. Spine (Phila Pa 1976). 2012;37: E668-E677.
  • Bansback N, Zhang W, Walsh D, et al. Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA. Rheumatology (Oxford). 2012;51:375–384.
  • Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012;19:703–711.
  • Ozgur E, Straub K, Wille S, Engelmann U, Dagtekin O, Gerbershagen HJ. Impact of preoperative pain on postoperative pain chronification. Six-month follow-up after urologic surgery. Urologe A. 2011;50:1396–1402. German.
  • Bigal ME, Lipton RB. Migraine chronification. Curr Neurol Neurosci Rep. 2011;11:139–148.
  • Woolf A, Zeidler H, Haglund U, et al. Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries. Ann Rheum Dis. 2004;63: 342–347.
  • Ferreira-Valente MA, Ribeiro JL, Jensen MP, Almeida R. Coping with chronic musculoskeletal pain in Portugal and in the United States: a cross-cultural study. Pain Med. 2011;12:1470–1480.
  • Wise EA, Price DD, Myers CD, Heft MW, Robinson ME. Gender role expectations of pain: relationship to experimental pain perception. Pain. 2002;96:335–342.
  • Fillingim RB. Sex, gender, and pain: women and men really are different. Curr Rev Pain. 2000;4:24–30.
  • Kocoglu D, Ozdemir L. The relation between pain and pain beliefs and sociodemographic-economic characteristics in an adult population. Agri. 2011;23:64–70. Turkish.
  • Davies KA, Silman AJ, Macfarlane GJ, et al. The association between neighbourhood socio-economic status and the onset of chronic widespread pain: results from the EPIFUND study. Eur J Pain. 2009;13: 635–640.
  • Defrin R, Eli I, Pud D. Interactions among sex, ethnicity, religion, and gender role expectations of pain. GendMed. 2011;8:172–183.
  • Gibson S, Helme R. Age-related differences in pain perception and report. Clin Geriatr Med. 2001;17:433–456.
  • Wilson AC, Lewandowski AS, Palermo TM. Fear-avoidance beliefs and parental responses to pain in adolescents with chronic pain. Pain ResManag. 2011;16:178–182.
  • Meeker MA, Finnell D, Othman AK. Family caregivers and cancer pain management: a review. J Fam Nurs. 2011;17:29–60.
  • Katz JN, Lyons N, Wolff LS, et al. Medical decision-making among Hispanics and non-Hispanic whites with chronic back and knee pain: a qualitative study. BMC Musculoskelet Disord. 2011;12:78.
  • Edwards RR, Moric M, Husfeldt B, Buvanendran A, Ivankovich O. Ethnic similarities and differences in the chronic pain experience: a comparison of african american, Hispanic, and white patients. Pain Med. 2005;6:88–98.
  • Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth. 2008;101:17–24.
  • Ni Thuathail A, Welford C. Pain assessment tools for older people with cognitive impairment. Nurs Stand. 2011;26:39–46.
  • Freynhagen R, Wirz S, Rolke R. Diagnosis of neuropathic pain. Ther Umsch. 2011;68:495–500. German.
  • Mehra M, Hill K, Nicholl D, Schadrack J. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis. J Med Econ. 2012;15:245–252.
  • Park J, Hughes AK. Nonpharmacological approaches to the management of chronic pain in community-dwelling older adults: a review of empirical evidence. J Am Geriatr Soc. 2012;60:555–568.
  • Thieme K, Gracely R. Are psychological treatments effective for fibromyalgia pain? Curr Rheum Rep. 2009;11:443–450.
  • Kasper S. The psychiatrist confronted with a fibromyalgia patient. Hum Psychopharmacol. 2009;24 Suppl 1:S25–S30.
  • Yaster M, Kost-Byerly S, Maxwell L. The management of pain in sickle cell disease. Ped Clin N Amer. 2000;47:699–710.
  • Molsberger A. Acupuncture in orthopedics. Orthopade. 2012;41:100–105. German.
  • Rispler D, Sara J, Davenport L, Mills B, Iskra C. Underreporting of complementary and alternative medicine use among arthritis patients in an orthopedic clinic. Am J Orthop (Belle MeadNJ). 2011;40:E92–E95.
  • Mick G, Correa-Illanes G. Topical pain management with the 5% lidocaine medicated plaster – a review. Curr Med Res Opin. 2012;28: 937–951.
  • Lionberger D, Brennan M. Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch. J Pain Res. 2010;3:223–233.
  • Gaudioso C, Hao J, Martin-Eauclaire MF, Gabriac M, Delmas P. Menthol pain relief through cumulative inactivation of voltage-gated sodium channels. Pain. 2012;153:473–484.
  • Pergolizzi J, Pappagallo M, Raffa R, et al. Preliminary observations of a novel topical oil with analgesic properties for treatment of acute and chronic pain syndromes. Pain Pract. 2010;10:201–213.
  • Taylor R Jr, Gan TJ, Raffa RB, et al. A randomized, double-blind comparison shows the addition of oxygenated glycerol triesters to topical mentholated cream for the treatment of acute musculoskeletal pain demonstrates incremental benefit over time. Pain Pract. February 5, 2011. [Epub ahead of print.]
  • Jorge LL, Feres CC, Teles VE. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res. 2011;4:11–24.
  • Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth. 2011;107:490–502.
  • Toussaint K, Yang X, Zielinski M, et al. What do we (not) know about how paracetamol (acetaminophen) works? J Clin Pharm Ther. 2010; 35(6):617–638.
  • James L, Letzig L, Simpson P, et al. Pharmacokinetics of acetamino-phen-protein adducts in adults with acetaminophen overdose and acute liver failure. DrugMetab Dispos. 2009;37:1779–1784.
  • Bower W, Johns M, Margolis H, Williams I, Bell B. Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007; 102: 2459–2463.
  • Bronstein A, Spyker D, Cantilena L, Green J, Rumack B, Griffin S. 2008 annual report of the American Association of Poison Control Centers’ national poison data system (NPDS): 26th annual report. Clin Toxicol. 2009;47:911–1084.
  • Sudano I, Flammer A, Periat D, et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation. 2010;122: 1789–1796.
  • Montgomery B. Does paracetamol cause hypertension? BMJ. 2008;336:1190–1191.
  • White W, Campbell P. Blood pressure destabilization on nonsteroidal antiinflammatory agents: acetaminophen exposed? Circulation. 2010; 122:1779–1781.
  • Doherty M, Hawkey C, Goulder M, et al. A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain. Ann Rheum Dis. 2011;70:1534–1541.
  • Zhang W, Nuki G, Moskowitz R, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18: 476–499.
  • Altman R. Practical considerations for the pharmacologic management of osteoarthritis. Am J Manag Care. 2009;15:S236–S243.
  • Rao P, Knaus E. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008;11:81s–110s.
  • Ng S, Chan F. NSAID-induced gastrointestinal and cardiovascular injury. Curr Opin Gastroenterol. 2010;26:611–617.
  • Lanas A, Perez-Aisa M, Feu F, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol. 2005;100:1685–1693.
  • Schjerning-Olsen A, Fosbøl E, Lindhardsen J, et al. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Circulation. 2011;123: 2226–2235.
  • European Medicines Agency. Opinion of the committee for medicinal products for human use pursuant to the article 5(3) of regulation (EC) no 726/2004, for nonselective non-steroidal anti-inflammatory drugs (NSAIDs). 2006. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/0ther/2010/01/WC500054342.pdf. Accessed March 11, 2012.
  • American Geriatric Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57: 1331–1346.
  • Anastassopoulos KP, Chow W, Ackerman SJ, Tapia C, Benson C, Kim MS. Oxycodone-related side effects: impact on degree of bother, adherence, pain relief, satisfaction, and quality of life. J Opioid Manag. 2011;7:203–215.
  • Rosti G, Gatti A, Costantini A, Sabato AF, Zucco F. Opioid-related bowel dysfunction: prevalence and identification of predictive factors in a large sample of Italian patients on chronic treatment. Eur Rev Med Pharmacol Sci. 2010;14:1045–1050.
  • Solomon D, Rassen J, Glynn R, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med. 2010;170:1968–1976.
  • Sullivan M, Von Korff M, Banta-Green C, Merrill J, Saunders K. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain. 2010;149:345–353.
  • Passero C, McCaffery M. Opioid-induced hyperalgesia. J Perianesth Nurs. 2012;27:46–50.
  • Raffa R, Pergolizzi J. Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients? Pain Manag Nurs. 2012. In press.
  • Adams E, Breiner S, Cicero T, et al. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage. 2006;31:465–476.
  • Tramadol hydrochloride 50 mg capsules. The Electronic Medicines Compendium. 2011. Available from: http://www.medicines.org.uk/emc/medicine/24186/SPC/tramadol%20hydrochloride%2050mg%20 capsules/. Accessed December 15, 2011.
  • Raffa R. Pharmacological aspects of successful long-term analgesia. Clin Rheumatol. 2006;25 Suppl 1:S9–S15.
  • Raffa R, Clark-Vetri R, Tallarida R, Wertheimer A. Combination strategies for pain management. Expert Opin Pharmacother. 2003;4: 1697–1708.
  • Schilling A, Corey R, Leonard M, Eghtesad B. Acetaminophen: old drug, new warnings. Cleve Clin J Med. 2010;77:19–27.
  • Raffa R, Friderichs E, Reimann W, Shank R, Codd E, Vaught J. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. J Pharmacol Exp Ther. 1992;260:275–285.
  • Filitz J, Ihmsen H, Günther W, et al. Supra-additive effects of tramadol and acetaminophen in a human pain model. Pain Manag Nurs. 2008;136:262–270.
  • Perrot S, Krause D, Crozes P, Naim C. Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallelgroup, 10-day treatment study. Clin Ther. 2006;28:1592–1606.
  • Rawal N, Macquaire V, Catala E, Berti M, Costa R, Wietlisbach M. Tramadol/paracetamol combination tablet for postoperative pain following ambulatory hand surgery: a double-blind, double-dummy, randomized, parallel-group trial. J Pain Res. 2011;4:103–110.
  • Mejjad O, Serrie A, Ganry H. Epidemiological data, efficacy and safety of a paracetamol-tramadol fixed combination in the treatment of moderate-to-severe pain. SALZA: a post-marketing study in general practice. Curr Med Res Opin. 2011;27:1013–1020.
  • Hewitt D, Todd K, Xiang J, Jordan D, Rosenthal N. Tramadol/acetaminophen or hydrocodone/acetaminophen for the treatment of ankle sprain: a randomized, placebo-controlled trial. Ann Emerg Med. 2007;49:468–480.
  • Lee E, Lee E, Park B, et al. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial. Clin Ther. 2006;28:2052–2060.
  • Raffaeli W, Pari C, Corvetta A, et al. Oxycodone/acetaminophen at low dosage: an alternative pain treatment for patients with rheumatoid arthritis. J Opioid Manag. 2010;6:40–46.
  • Choi C, Song J, Kang Y, et al. A 2-week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain. Clin Ther. 2007;29:1381–1389.
  • Corsinovi L, Martinelli E, Fonte G, et al. Efficacy of oxycodone/acetaminophen and codeine/acetaminophen vs conventional therapy in elderly women with persistent, moderate to severe osteoarthritis-related pain. Arch Gerontol Geriatr. 2009;49:378–382.
  • Pareek A, Chandurkar N, Ambade R, Chandanwale A, Bartakke G. Efficacy and safety of etodolac-paracetamol fixed dose combination in patients with knee osteoarthritis flare-up: a randomized, double-blind comparative evaluation. Clin J Pain. 2010;26:561–566.
  • Conaghan P, O’Brien C, Wilson M, Schofield J. Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and/or knee: a randomised trial. Osteoarthritis Cartilage. 2011;19:930–938.
  • Palangio M, Morris E, Doyle RJ, Dornseif B, Valente T. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain. Clin Ther. 2002;24:87–99.
  • Ruoff G, Rosenthal N, Jordan D, Karim R, Kamin M. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther. 2003;25:1123–1141.
  • Silberstein SD, Mannix LK, Goldstein J, et al. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine. Neurology. 2008;71:114–121.
  • Pfaffenrath V, Diener HC, Pageler L, Peil H, Aicher B. OTC analgesics in headache treatment: open-label phase vs randomized double-blind phase of a large clinical trial. Headache. 2009;49:638–645.
  • Diener HC, Peil H, Aicher B. The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: a post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebocontrolled parallel group study. Cephalalgia. 2011;31:1466–1476.
  • Bennett R, Kamin M, Kamin R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Cardiol. 2003;114:537–545.
  • Ko S, Kwon H, Yu J, et al. Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy. Diabet Med. 2010;27: 1033–1040.
  • White P, Joshi G, Carpenter R, Fragen R. A comparison of oral ketorolac and hydrocodone-acetaminophen for analgesia after ambulatory surgery: arhroscopy versus laparoscopic tubal ligation. Anesth Analg. 1997;85:37–43.
  • Sniezek P, Brodland D, Zitelli J. A randomized controlled trial comparing acetaminophen, acetaminophen and ibuprofen, and acetaminophen and codeine for postoperative pain relief after Mohs surgery and cutaneous reconstruction. Dermatol Surg. 2011;37:1007–1013.
  • Zhang W, Moskowitz R, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16:137–162.
  • Antman E, Bennett J, Daugherty A, Furberg C, Roberts H, Taubert K. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115:1634–1642.
  • National Institute for Health and Clinical Excellence. The care and management of osteoarthritis in adults. 2008. Available from: http://www.nice.org.uk/nicemedia/pdf/CG59NICEguideline.pdf. Accessed December 15, 2010.
  • Schnitzer T. Update on guidelines for the treatment of chronic mus-culoskeltal pain. Clin Rheumatol. 2006;25 Suppl 1:S22–S29.
  • Altman R. Early management of osteoarthritis. Am J Manag Care. 2010;16:S41–S47.
  • NICE. Rheumatoid arthritis: the management of rheumatoid arthritis in adults. NICE Clinical Guideline 2009. Available from: http://www.nice.org.uk/nicemedia/live/12131/43327/43327.pdf. Accessed December 18, 2010.
  • Luqmani R, Hennell S, Estrach C, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years). Rheumatology (Oxford). 2006;45:1167–1169.
  • Luqmani R, Hennell S, Estrach C, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology (Oxford). 2009;48:436–439.
  • Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:34–45.
  • Carville S, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536–541.
  • Buckhardt C, Goldenberg D, Crofford L, et al. Guideline for the management of fibromyalgia syndrome pain in adults and children. Clinical practice guideline no. 4. 2005. Available from: http://www.ampainsoc.org/pub/fibromyalgia.htm. Accessed December 18, 2010.
  • Airaksinen O, Brox J, Cedraschi C, et al. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006;15 Suppl 2:S192–S300.
  • Chou R, Hoyt-Huffman L. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147:505–514.
  • National Institute for Health and Clinical Excellence. Low back pain: early management of persistent non-specific low back pain. 2009. Available from: http://www.nice.org.uk/nicemedia/live/11887/44343/44343.pdf. Accessed December 18, 2010.
  • Pergolizzi J, Labhsetwar S, Puenpatom R, Joo S, Ben-Joseph R, Summers K. Prevalence of exposure to potential CYP450 pharmacokinetic drug-drug interactions among patients with chronic low back pain taking opioids. Pain Pract. 2011;11:230–239.
  • Daly F, Fountain J, Murray L, Graudins A, Buckley N. Guidelines for the management of paracetamol poisoning in Australia and New Zealand – explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust. 2008;188:296–301.
  • World Health Organization. WHO’s pain ladder. 1986. Available from: http://www.who.int/cancer/palliative/painladder/en/. Accessed June 15, 2012.
  • Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Can Fam Physician. 2010;56:514–517.
  • Pergolizzi J, Alegre C, Blake D, et al. Current considerations for the treatment of severe chronic pain: the potential for tapentadol. Pain Pract. 2012;12:290–306.